The safety, tolerability and preliminary efficacy of pd-l1 monoclonal antibody combined with lenalidomide in third-line post-treatment of patients with microsatellite stable advanced colorectal cancer: a phase I clinical stud

ABSTRACT: Interventions: single arm:Pd-l1 monoclonal antibody and lenalidomide Primary outcome(s): Security;Tolerance Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2691549 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR